Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 23, Number 2—February 2017

CME ACTIVITY - Research

Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel

CME Logo

Earning CME Credit

To obtain credit, you should first read the journal article. After reading the article, you should be able to answer the following, related, multiple-choice questions. To complete the questions (with a minimum 75% passing score) and earn continuing medical education (CME) credit, please go to http://www.medscape.org/journal/eid. Credit cannot be obtained for tests completed on paper, although you may use the worksheet below to keep a record of your answers. You must be a registered user on Medscape.org. If you are not registered on Medscape.org, please click on the “Register” link on the right hand side of the website to register. Only one answer is correct for each question. Once you successfully answer all post-test questions you will be able to view and/or print your certificate. For questions regarding the content of this activity, contact the accredited provider, CME@medscape.net. For technical assistance, contact CME@webmd.net. American Medical Association’s Physician’s Recognition Award (AMA PRA) credits are accepted in the US as evidence of participation in CME activities. For further information on this award, please refer to http://www.ama-assn.org/ama/pub/about-ama/awards/ama-physicians-recognition-award.page. The AMA has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credits™. Through agreements that the AMA has made with agencies in some countries, AMA PRA credit may be acceptable as evidence of participation in CME activities. If you are not licensed in the US, please complete the questions online, print the certificate and present it to your national medical association for review.

Article Title: Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel

CME Questions

1. Which of the following statements regarding the phylogenetic trees of Candida auris and C. haemulonii in the current study is most accurate?

A. Both Candida strains were closely linked with singular global international clones

B. C. auris was distinct from other global isolates; C. haemulonii was similar to a single global isolate

C. C. auris was similar to a single global isolate; C. haemulonii was distinct from other global isolates

D. Both Candida strains were distinct from other global isolates

2. Which of the following statements regarding patient characteristics in the current study of C. auris and C. haemulonii infection is most accurate?

A. Most cases of C. auris infection were isolated from skin samples

B. Carriers of C. haemulonii tended to be younger and healthier compared with noncarriers

C. C. haemulonii was most frequently recovered from sites of healed lower extremity ulcers

D. Cultures of medical personnel and equipment implicated chronic facility colonization with C. haemulonii

3. C. auris and C. haemulonii were most likely to be resistant to which of the following antifungals in the current study?

A. Fluconazole

B. Anidulafungin

C. Micafungin

D. Flucytosine

4. What else did the current study demonstrate regarding the pathologic potential of C. auris and C. haemulonii?

A. C. auris demonstrated greater potential for azole resistance compared with C. haemulonii

B. The potential for azole resistance in C. auris and C. haemulonii was not as strong as that of C. glabrata

C. Only C. auris grew poorly at high temperatures

D. Both C. auris and C. haemulonii grew poorly at high temperatures

Activity Evaluation

1. The activity supported the learning objectives.

Strongly Disagree

Strongly Agree

1

2

3

4

5

2. The material was organized clearly for learning to occur.

Strongly Disagree

Strongly Agree

1

2

3

4

5

3. The content learned from this activity will impact my practice.

Strongly Disagree

Strongly Agree

1

2

3

4

5

4. The activity was presented objectively and free of commercial bias.

Strongly Disagree

Strongly Agree

1

2

3

4

5

>

Article Navigation

TOP